← stocks-llm Find companies like ALEC →

ALECTOR INC (ALEC)

Health Care · Clinical-stage biotechnology / drug development · NASDAQ

An early-stage biotech company developing novel therapeutic candidates for neurodegenerative diseases through preclinical research and clinical trials.

View SEC filings Website Yahoo Finance Find companies like ALEC → Ask about ALEC →

What ALECTOR INC does

Alector is a preclinical and clinical-stage biotechnology company focused on the research and development of therapeutic product candidates, primarily through the advancement of research programs from preclinical stages into clinical development. The company is targeting specific disease indications and pursuing regulatory approvals, including orphan drug designations where applicable. Alector relies on third-party collaborators and manufacturers to conduct clinical trials and manufacture product candidates.

Themes: ["clinical-stage biotechnology","drug development","preclinical research","orphan drug designation","neurology / neurodegeneration"]

Fundamentals

Ask why ALEC looks like this →

Key risks (from latest filing)

["Clinical trial failure risk: ability to demonstrate safety and efficacy of product candidates in clinical trials is uncertain and actual results may differ materially from expectations","Regulatory approval risk: company must obtain and maintain regulatory approval of product candidates, with timing and likelihood of approvals uncertain","Manufacturing and third-party dependence: continued reliance on third parties to conduct clinical trials and manufacture product candidates for preclinical studies and clinical trials"]

See ALEC's biggest risks from its latest 10-Q →

Competitors & peers

Not quite? Describe exactly what you want →

Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.

Last updated 2026-07-09.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.